Identification of KLHL12 Ligands Using Fragment-Based Methods

Read full text
Authors: Alex G. Waterson, Anish Vadukoot, Somnath Jana, Jianwen Cui, Kelvin Luong, Tyson A. Rietz, Ezequiel Alejandro Madrigal-Carrillo, Brian D. Lehmann, John Sensintaffar, Bin Zhao, Kangsa Amporndanai, Zoe A. Petros
+15 more W. Rush Scaggs, Selena Chacón Simon, Rakesh H. Vekariya, Kwangho Kim, Manikandan Thangaraj, Plamen P. Christov, Taylor M. South, Jiqing Sai, Anusha Thiruvaipati, Charles Schmidt, Rebecca Eells, William Moore, Edward T. Olejniczak, Jason Phan, Stephen W. Fesik
Cited by: 2
References: 33

Abstract

Targeted protein degradation can be induced by recruiting a protein of interest to an E3 ligase, resulting in its ubiquitination and subsequent proteasome-mediated degradation. However, only a small number of E3 ligases have been utilized for degradation. Expansion of the repertoire of useful E3 ligases via the identification of ligands to those ligases could broaden the scope and applicability of the degradation paradigm. We have identified KLHL12 as an E3 ligase with higher expression in cancer over normal tissues. We report here the use of NMR-based screening to identify fragments that bind to KLHL12, and X-ray structures of a fragment hit bound to KLHL12. Using this structural information, we optimized the hits, leading to the first reported small molecules that bind to KLHL12 with submicromolar affinity. Derivatives of these compounds may be useful for the construction of PROTACs to selectively degrade protein targets in tumors while sparing normal cells.

Fields of Study & Subjects

Protein Degradation and Inhibitors Ubiquitin and proteasome pathways Peptidase Inhibition and Analysis

Publication details

Journal / source
Journal of Medicinal Chemistry
Publisher
American Chemical Society (ACS)
Volume
69
Issue
7
Pages
7709–7731
Publication date
30 March 2026
Language
EN